School of Medicine
Showing 3,901-4,000 of 12,928 Results
-
Neelam Goyal, MD
Clinical Professor, Adult Neurology
Current Research and Scholarly InterestsDr. Goyal's research interests involve monitoring and managing the short and long-term toxicity of immunosuppressive agents used in the treatment of immune-mediated neuromuscular disorders. She is actively involved in a grant-supported project investigating steroid toxicity in patients with myasthenia gravis.
She also serves as the Wellbeing Co-Director for the Neurology Department, working on a grant-supported project aimed at mitigating the adverse impact of work on personal relationships. -
Varun Goyal
Postdoctoral Scholar, Otolaryngology - Head & Neck Surgery
BioDr. Varun Goyal is a Postdoctoral Scholar in Otolaryngology at Stanford University, applying his expertise in nonlinear systems, biomechanics, acoustics, and vibrations to advance the understanding of hearing. He earned his Ph.D. in Mechanical Engineering from the University of Michigan, where he worked at the intersection of mechanics and biological systems to develop computational frameworks for mechanosensory transduction in mammalian ears, with a particular focus on inner-ear hair bundles.
His background spans structural and fluid dynamics, finite element analysis, and control systems, with a strong emphasis on applying these techniques to problems in ear physiology. Dr. Goyal also conducted research at the Center for Nondestructive Evaluation (CNDE) during his bachelor's and master’s studies at IIT Madras, where he designed multifunctional acoustic waveguides for ultrasonic energy transmission and temperature sensing.
He has led and contributed to high-impact R&D projects across leading academic institutions, including RWTH Aachen University in Germany, Nanyang Technological University in Singapore, and Nagaoka University of Technology in Japan, as well as industry partners such as Mondelez International and Plasma Giken Co., Ltd. in Japan. Driven by curiosity and a commitment to understanding how complex systems operate, Dr. Goyal's work integrates theory, computation, and experiment to address fundamental questions in auditory biomechanics. -
Or Gozani
Dr. Morris Herzstein Professor
Current Research and Scholarly InterestsWe study the molecular mechanisms by which chromatin-signaling networks effect nuclear and epigenetic programs, and how dysregulation of these pathways leads to disease. Our work centers on the biology of lysine methylation, a principal chromatin-regulatory mechanism that directs epigenetic processes. We study how lysine methylation events are generated, sensed, and transduced, and how these chemical marks integrate with other nuclear signaling systems to govern diverse cellular functions.
-
Joshua D. Grab, MS, MA
Biostatistician 2, Stanford-Surgery Policy Improvement Research and Education Center
BioJoshua Grab is a Biostatistician at the S-SPIRE Center in the Department of Surgery. He has Masters' degrees in Biostatistics and Mathematics.
Josh has 12 years of experience as a biostatistician and data analyst. As a data analyst at UCSF, he worked primarily for the Liver Transplant Center doing survival analyses. At Wake Forest University, he worked on genome-wide association studies for various disease conditions. Before that, he worked at the Duke Clinical Research Institute (DCRI), building logistic models for mortality within the Society of Thoracic Surgeons' National Cardiac Database.
Josh has been a SAS user for all of his time in biostatistics and has beginner to intermediate skills with various other software packages, including R, STATA, and MATLAB, and is learning Python.
In addition to his biostatistics career, Josh also has 7 years of experience teaching mathematics and introductory statistics at the community college level. -
Erin Elizabeth Grady
Clinical Professor, Radiology - Rad/Nuclear Medicine
BioErin Grady, MD, CCD, FACNM, FSNMMI is a nuclear medicine physician at Stanford Hospital and Clinics in Stanford, California. She serves as the Interim Division Chief of Nuclear Medicine and Molecular Imaging, Associate Chair of Education and Diversity, Equity and Inclusion, and is program director for the nuclear radiology and nuclear oncology fellowship programs, as well as a coach for the diagnostic radiology program. She is actively involved nationally in the Society of Nuclear Medicine and Molecular Imaging as a Director-at-Large on the SNMMI Board of Directors, and chair of the Government Relations Committee. She serves on the Nuclear Medicine Residency Review Committee for ACGME appeals panel member and assisted with milestone 1.0 development committee for Nuclear Medicine and 2.0 milestone revision committee for Nuclear Radiology at the ACGME. She has been involved in multiple guideline and appropriate use documents on topics related to thyroid cancer (NCCN panel), neuroendocrine tumors, bone scintigraphy, lung scintigraphy and more. In addition, she is a past chair of the American Board of Nuclear Medicine and past president of the American College of Nuclear Medicine. Her areas of research interest include quality, education, radiopharmaceutical therapy and finding answers to clinical questions that arise during the course of practice. She is passionate about education, nuclear medicine’s future, collaboration across specialties, and is a staunch advocate for patients.
-
Sally Graglia
Clinical Associate Professor, Emergency Medicine
BioDr. Graglia, the youngest of four in an immigrant family, grew up in Southern California. Considering veterinary medicine, journalism, architecture, and Disney animation, Dr. Graglia ‘discovered people’ during a summer in undergrad working in Ethiopia, decided on medicine as her path forward, and has never looked back.
A UC child, she completed her undergraduate studies at UC Berkeley, medical school at UC Davis, and residency at UCSF with deviations to the Johns Hopkins Bloomberg School of Public Health for a Masters of Public Health and Massachusetts General Hospital (MGH) for fellowship in Emergency Ultrasound.
Having worked, learned, and/or taught throughout Africa, Europe and Eastern Europe, and Central and South America, her three pillars continue to be point-of-care ultrasound (POCUS), education, and global health with an unending drive to serve the underserved.
Outside of work, Dr. Graglia enjoys her growing family, yoga, hiking, being outside, and exploring - new cultures, places, and languages. -
Britni Wilcher
Affiliate, Health Policy
Visiting Scholar, Health PolicyBioBritni Wilcher, PhD, is a Visiting Scholar in the Department of Health Policy at Stanford University and an applied microeconomist working at the intersection of health, labor, and gender economics. Dr. Wilcher's research focuses on the economics of health decision making and its implications for labor markets using quasi-experimental designs. Her research portfolio spans vulnerable populations and policy interventions, from evaluating teletherapy adoption patterns among 200,000+ veterans to conducting regulatory impact analyses protecting 22+ million workers nationwide. Her collaborative research products have withstood judicial review up to the Supreme Court and provided evidence-based input into policy actions. Her work has been cited in congressional testimony and the 2022 Economic Report of the President. It has been featured in federal regulations and published in peer-reviewed journals including Labour Economics, Health Economics, Value in Health, and the International Journal of Technology Assessment in Health Care.
Dr. Wilcher has worked in management consulting, government, universities, and has consulted with think tanks, foundations, the EU Commission, and a United Nations entity. She holds a PhD in Economics from American University, an MSc in International Health Care Management, Economics, and Policy from SDA Bocconi School of Management, and a BA in Economics from Spelman College. -
Laura Graham
Other Teaching Staff-Hourly, Surgery
BioI am an epidemiologist and health services researcher with nearly 20 years of experience in surgical outcomes research. My work focuses on improving healthcare delivery and outcomes for Veterans and other vulnerable populations, particularly those who are older or medically complex. Using large administrative datasets from the Veterans Health Administration (VA), I study surgical processes and outcomes to inform system-level improvements.
With postdoctoral training in health economics and implementation science, I bring expertise in causal inference methodology and artificial intelligence, particularly the use of natural language processing (NLP). I apply these methods to extract insights from unstructured clinical data and to strengthen causal analyses in complex healthcare datasets. These approaches allow me to address research questions that were previously difficult to study with standard empirical approaches.
As a collaborative leader, I have mentored junior investigators and worked across academic and industry sectors to advance health services research. My goal is to translate evidence into practice, ultimately improving the quality of surgical care for Veterans. -
Philip Grant
Clinical Associate Professor, Medicine - Infectious Diseases
BioMy research focuses on antiretroviral therapy and complications of HIV including immune reconstitution inflammatory disease, osteoporosis, and cardiovascular disease.
-
Teodor Grantcharov, MD, PhD, FACS, FRCS (Glasg)
Professor of Surgery (General Surgery)
BioDr. Teodor Grantcharov completed his surgical training at the University of Copenhagen, and a doctoral degree in Medical Sciences at the University of Aarhus in Denmark.
Dr. Grantcharov is a Professor of Surgery at Stanford University and Associate Chief Quality Officer for Innovation and Safety at Stanford Healthcare.
Prior to joining Stanford, Dr. Grantcharov was a Professor of Surgery at the University of Toronto and Keenan Chair in Surgery at St. Michael’s Hospital in Toronto. He was the Founder of the International Centre for Surgical Safety – a multidisciplinary group of visionary scientists with expertise in design, human factors, computer- and data science, and healthcare research. He previously held Canada Research Chair in Simulation and Surgical Safety and was awarded the Queen Elizabeth II diamond jubilee medal for his contributions to clinical research and patient safety in Canada. Dr. Grantcharov was awarded the honorary fellowship of the Imperial College in London, the honorary fellowships of the Bulgarian, Danish and Brazilian surgical societies, the Spinoza Chair in Surgery from the University of Amsterdam and multiple national and international awards for his contributions to surgical education and surgical safety.
Dr. Grantcharov’s clinical interest is the area of minimally invasive surgery, while his academic focus is in the field of surgical innovation and patient safety. He has become internationally recognized as a leader in this area with his work on curriculum design, assessment of competence and impact of surgical performance on clinical outcomes. Dr. Grantcharov developed the surgical Black Box concept, which aims to transform the safety culture in medicine and introduce modern safety management systems in the high-risk operating room environment.
Dr. Grantcharov has more than 220 peer-reviewed publications and more than 200 invited presentations in Europe, South- and North America. He holds several patents and is the Founder of Surgical Safety Technologies Inc – an academic startup that commercializes the OR Black Box platform. He sits on numerous committees with Surgical Professional Societies in North America and Europe. -
Dita Gratzinger
Professor of Pathology
Current Research and Scholarly InterestsI have research interests in the interaction of normal and neoplastic hematolymphoid cells with the bone marrow. lymph node and spleen microenvironment and the interactions of these compartments with immune perturbation and dysregulation.
-
Edward Graves
Professor of Radiation Oncology (Radiation Physics), and by courtesy, of Radiology
Current Research and Scholarly InterestsApplications of molecular imaging in radiation therapy, small animal image-guided conformal radiotherapy, immune responses to radiation, immunotherapy and radiotherapy combinations, image processing and analysis.
-
Nathanael S. Gray
Krishnan-Shah Family Professor
BioNathanael Gray is the Krishnan-Shah Family Professor of Chemical and Systems Biology at Stanford, Co-Director of Cancer Drug Discovery Co-Leader of the Cancer Therapeutics Research Program, Member of Chem-H, and Program Leader for Small Molecule Drug Discovery for the Innovative Medicines Accelerator (IMA). His research utilizes the tools of synthetic chemistry, protein biochemistry, and cancer biology to discover and validate new strategies for the inhibition of anti-cancer targets. Dr. Gray’s research has had broad impact in the areas of kinase inhibitor design and in circumventing drug resistance.
Dr. Gray received his PhD in organic chemistry from the University of California at Berkeley in 1999 after receiving his BS degree with the highest honor award from the same institution in 1995. After completing his PhD, Dr. Gray was recruited to the newly established Genomics Institute of the Novartis Research Foundation (GNF) in San Diego, California. During his six year stay at GNF, Dr. Gray became the director of biological chemistry where he supervised a group of over fifty researchers integrating chemical, biological and pharmacological approaches towards the development of new experimental drugs. Some of the notable accomplishments of Dr. Gray’s team at GNF include: discovery of the first allosteric inhibitors of wild-type and mutant forms of BCR-ABL which resulted in clinical development of ABL001; discovery of the first selective inhibitors of the Anaplastic Lymphoma Kinase (ALK), an achievement that led to the development of now FDA-approved drugs such as ceritinib (LDK378) for the treatment of EML4-ALK expressing non-small cell lung cancer (NSCLC); and discovery that sphingosine-1-phosphate receptor-1 (S1P1) is the pharmacologically relevant target of the immunosuppressant drug Fingomilod (FTY720) followed by the development of Siponimod (BAF312), which is currently used for the treatment of multiple sclerosis.
In 2006, Dr. Gray returned to academia as a faculty member at the Dana Farber Cancer Institute and Harvard Medical School in Boston. There, he has established a discovery chemistry group that focuses on developing first-in-class inhibitors for newly emerging biological targets, including resistant alleles of existing targets, as well as inhibitors of well-validated targets, such as Her3 and RAS, that have previously been considered recalcitrant to small molecule drug development. Dr. Gray’s team developed covalent inhibitors of the T790M mutant of EGFR inspired the development of Osimertinib (AZD9291), now FDA approved for treatment of patients with relapsed lung cancer due to resistance to first generation EGFR inhibitors. Dr. Gray has also developed structure-based, generalized approaches for designing drugs to overcome one of the most common mechanisms of resistance observed against most kinase inhibitor drugs, mutation of the so-called "gatekeeper" residue, which has been observed in resistance to drugs targeting BCR-ABL, c-KIT and PDGFR.
In 2021, Dr. Gray joined Stanford University where he has joined the Stanford Cancer Institute, Chem-H and the Innovative Medicines Accelerator (IMA) to spur the development of prototype drugs.
These contributions have been recognized through numerous awards including the National Science Foundation’s Career award in 2007, the Damon Runyon Foundation Innovator award in 2008, the American Association for Cancer Research for Team Science in 2010 and for Outstanding Achievement in 2011 and the American Chemical Society award for Biological Chemistry in 2011, and the Nancy Lurie Marks endowed professorship in 2015 and the Paul Marks Prize in 2019, and the Hope Funds for Cancer Research in 2023. -
Carlos Greaves
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioBorn and raised in Caracas, Venezuela. Medical school at the Central University School of Medicine, where Internship was completed.
Residency training at Stanford Medical School, Department of Psychiatry. Work in Community Mental health in Maui, Hawaii for 4 years.
Work at the Veterans Administration in Palo Alto for 3 years. Currently in Private Practice and as consulting psychiatrist at the Vaden Student Health center at Stanford -
Henry T. (Hank) Greely
Deane F. and Kate Edelman Johnson Professor of Law and, Professor, by courtesy, of Genetics
Current Research and Scholarly InterestsSince 1992 my work has concentrated on ethical, legal, and social issues in the biosciences. I am particularly active on issues arising from neuroscience, human genetics, and stem cell research, with cross-cutting interests in human research protections, human biological enhancement, and the future of human reproduction.
-
Larry L. Green
Financial Analyst 3, Anesthesiology, Perioperative and Pain Medicine
Current Role at StanfordFinance Manager, Department of Anesthesia
-
Seth Ariel Green
Professional-NX, Pediatrics
Current Role at StanfordResearch Scientist at the Humane and Sustainable Food Lab
-
Sherril L. Green, DVM, PhD
Professor of Comparative Medicine, Emerita
Current Research and Scholarly InterestsResearch Interests: Xenopus laevis. Husbandry, biology, infectious and parasitic diseases of laboratory Xenopus laevis. Large animal models of disease.
-
Tamar Green
Associate Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Sciences) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsThe Brain Imaging, Development, and Genetic (BRIDGE) Lab focuses on disorders associated with child development, such as attention deficits, hyperactivity, and autism spectrum disorders. we aim to uncover biological principles of how genetic variation and its associated downstream pathways affect children's neurodevelopmental disorders.
-
Yoel Green, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Yoel Green is a board-certified, fellowship-trained sleep medicine specialist at Stanford Health Care. He also serves as a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences, Division of Sleep Medicine at Stanford University School of Medicine.
Dr. Green specializes in the diagnosis and treatment of sleep disorders, including narcolepsy, parasomnias, and obstructive sleep apnea (OSA). He also diagnoses and treats sleep-wake cycle disorders and restless legs syndrome (RLS). He integrates sleep data with patients’ lived experience to provide clear, personalized care.
Dr. Green’s research focuses on improving the diagnosis and treatment of sleep disorders. His work has appeared in peer-reviewed journals such as Biological Psychiatry and SLEEP. He has authored textbook chapters and presented at national meetings, including the American Psychiatric Association (APA) Annual Meeting.
Dr. Green is a member of the American Academy of Sleep Medicine, the APA, and the Canadian Sleep Society. -
Benjamin Daniel Greenberg
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Greenberg provides direct psychological care to patients in the ADAPT (Adult Depression and Anxiety Psychological Treatment) & Dual Diagnosis clinics. He is passionate about delivering evidence-based psychotherapies that are responsive and personal. He conducts individual as well as group therapy.
He teaches a psychotherapy didactic to the Addiction Medicine fellows as well as provides clinical supervision to post-doctoral fellows, doctoral students, and psychiatry residents. He is committed to helping trainees learn & work through complex situations that arise in individual & group psychotherapy. -
Harry B Greenberg
Joseph D. Grant Professor in the School of Medicine, Emeritus
Current Research and Scholarly InterestsMolecular mechanisms of pathogenesis; determinants of protective immunity; host range and tissue tropism in liver and GI tract pathogenic viruses and studies of vaccines in people.
-
Peter Greenberg
Professor of Medicine (Hematology), Emeritus
Current Research and Scholarly InterestsDr Greenberg's clinical research involves design and coordination of clinical trials using experimental drugs with biologic focus for both lower and higher risk MDS patients not responding to standard therapies. These studies are particularly based on his prior laboratory investigations of gene expression and hematopoietic regulation in MDS patients. He is Coordinator of the International Working Group for Prognosis in MDS (IWG-PM) which generated the revised MDS classification system (the IPSS-R) and the mutation-based prognostic risk system, the IPSS-Molecular (IPSS-M). This project uses such findings to more specifically characterize and treat MDS patients. He is Chair of the NCCN Practice Guidelines Panel for MDS.
-
Maxwell Greene, MD
Clinical Associate Professor, Adult Neurology
BioDr. Greene is a board-certified, fellowship-trained neurologist. He is also a Clinical Assistant Professor of Neurology at Stanford University School of Medicine.
Dr. Greene provides clinical care for adult patients with disorders of the muscles and peripheral nerves that cause weakness and numbness. He specializes in diagnosing and treating neuromuscular diseases that include amyotrophic lateral sclerosis (ALS), all types of muscular dystrophy, chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Charcot-Marie-Tooth (CMT). For CIDP and CMT, Stanford is one of the few centers of excellence in the country.
A significant part of Dr. Greene’s practice involves investigational work, where he seeks to determine the cause of a patient’s symptoms. In addition to performing the full range of diagnostic tests including interpreting biopsy procedures, he has special qualifications in electrodiagnosis and the use of electromyography and nerve conduction studies.
Treatments offered by Dr. Greene cover the complete spectrum of options, with an emphasis on immune therapies for certain conditions. For CIDP and myasthenia gravis, he administers immune globulin, steroids, plasmapheresis, and rituximab. To help manage symptoms of CMT and support areas of the body weakened by this disease, he can recommend physical therapy, occupational therapy, and foot, ankle, and knee orthotics.
For the treatment of ALS and muscular dystrophy, Dr. Greene leads a multidisciplinary team offering physical and occupational therapy, pulmonary expertise, speech and swallow expertise, nutrition counseling, social services, and specialized nursing, and works together with genetic counseling. All team members collaborate closely to ensure patients receive the care and comfort needed to meet their emotional as well as physical needs.
As part of his commitment to advancing patients’ treatment options, Dr. Greene conducts clinical research. Among his current interests are
innovative new therapies for ALS and other nerve and muscular disorders. This is an exciting time in the field of neuromuscular medicine, with real potential for treatment breakthroughs for the first time in decades. Exploring these new directions enables Dr. Greene to offer Stanford patients access to options that may not be available anywhere else.
To highlight new advances for his peers, Dr. Greene has made national and regional presentations at conferences including the American Academy of Neurology meeting. Topics include the results of a study supported in part by the National Institutes of Health: paraneoplastic antibodies as markers of Hodgkin’s disease. JAMA Neurology published Dr. Greene’s article on this research.
Dr. Greene’s achievements have earned recognition from the American Academy of Neurology and other organizations. He is also the recipient of a travel award from the American Neurological Association and a grant from the NIH National Institute of Neurological Disorders and Stroke.
A member of the American Academy of Neurology, Dr. Greene is also an active member of the Western ALS Consortium and Northeastern ALS Consortium. -
William Greenleaf
Professor of Genetics
Current Research and Scholarly InterestsOur lab focuses on developing methods to probe both the structure and function of molecules encoded by the genome, as well as the physical compaction and folding of the genome itself. Our efforts are split between building new tools to leverage the power of high-throughput sequencing technologies and cutting-edge optical microscopies, and bringing these technologies to bear against basic biological questions by linking DNA sequence, structure, and function.
-
J. Christian Greer
Lecturer, Psychiatry and Behavioral Sciences
BioJ. Christian Greer, PhD, is a scholar of Religious Studies with a special focus on psychedelic culture. He holds a MDiv from Harvard Divinity School, as well as a MA and PhD (cum laude) in Western Esotericism from the University of Amsterdam. While a postdoctoral researcher at Harvard Divinity School, he led a series of seminars on global psychedelic cultures, which culminated in the creation of the "Harvard Psychedelic Walking Tour," a free audio guide detailing how the Harvard community has shaped the modern history of psychedelic culture. He is also the co-founder, and currently the co-chair of the "Drugs and Religion" program unit at the American Academy of Religion.
His forthcoming book, "Angelheaded Hipsters: Psychedelic Militancy in Nineteen Eighties North America" (Oxford University Press), explores the expansion of psychedelic culture within fanzine networks in the late Cold War era. He has held teaching positions at Harvard University and Yale University, and is currently a lecturer at Stanford University. His other books include, "Void Machines: the Paper Shrines of J. Christian Greer," a collection of his esoteric artworks, and "Kumano Kodo: Pilgrimage to Powerspots" (co-authored with Dr. Michelle Oing) which analyzes the pilgrimage folklore associated with the rainforests of Japan's Kii Peninsula.
Each winter, he partners with the University of Amsterdam to offer an introduction to the study of occultism, hosted on ZOOM, entitled "FORBIDDEN KNOWLEDGE: Introduction to Esotericism." Similarly, each summer, he organizes an intensive summer school course on the University of Amsterdam's campus entitled, "THE PSYCHEDELIC UNIVERSE: Global Perspectives on Higher Consciousness." -
Michael Greicius, MD, MPH
Iqbal Farrukh and Asad Jamal Professor and Professor, by courtesy, of Psychiatry and Behavioral Sciences (Administrative and Academic Special Programs)
Current Research and Scholarly InterestsAs the Founding Director of the Stanford Center for Memory Disorders and Principal Investigator of a lab focused on the genetics of Alzheimer's disease (AD), Dr. Greicius' research focuses on elucidating the neurobiologic underpinnings of AD. His lab combines cutting edge brain imaging, "deep" phenotyping, and whole-genome sequencing of human subjects to identify novel pathways involved in AD pathogenesis. The goal of his work is to develop effective treatment for AD patients.
-
Karolina Grekov
Clinical Assistant Professor, Pediatrics - Critical Care
BioKarolina Grekov, MD, MA, serves as a Clinical Assistant Professor in Pediatric Critical Care, Pediatric Palliative Care, and Bioethics. Her academic interests include the nuanced role of language, culture, and spirituality in medical communication and shared decision-making. She completed her pediatric residency at Children's Hospital of Los Angeles (CHLA), where she also served as chief resident. She then went on to obtain advanced fellowship training in pediatric critical care at Lucile Packard Children's Hospital at Stanford where she served as chief fellow, and pediatric palliative care at Boston Children's Hospital in the Harvard Interprofessional Palliative Care Fellowship program.
-
Damanpreet Grewal
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioBeing from Bay Area, I enjoy providing medical care to patients in northern California. I am excited to be part of the wonderful team of gastroenterologists at Stanford University Medical Center with its multi-disciplinary approach to caring for patients in an integrated healthcare system. I am dedicated to providing high-quality care to my patients while getting to know their personal beliefs so as to involve them in the decision-making process. Based on my education and training, I practice general gastroenterology in addition to performing endoscopies and colonoscopies.
-
Paul C. Grimm
Professor of Pediatrics (Nephrology)
Current Research and Scholarly Intereststransplant tolerance
pediatric kidney transplant
cystinosis
prenatal nephrology
Point of Care Ultrasound (POCUS) -
Cornelius Botha Groenewald
Associate Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric)
BioDr. Groenewald is Director of Pediatric Anesthesiology Research at Stanford University School of Medicine. He conducts clinical research that crosses several areas related to child health, including epidemiology, health services research, pediatric pain, sleep deficiency, and opioid use behaviors. His research is funded by the National Institutes of Health, International Association for the Study of Pain, and the Society for Pediatric Anesthesiology. His work on pediatric pain, sleep disturbance, and opioid use has been published in JAMA Pediatrics, Pediatrics, PAIN, Journal of Pain, SLEEP, and JAMA Psychiatry. Dr. Groenewald holds national leadership positions in the United States Association for the Study of Pain, including being elected as inaugural Chair of the Pediatric Special Interest Group in 2020 and co-chair of the Advocacy committee in 2022. He serves on the editorial boards of the Journal of Pain and Pediatric Anesthesiology.
-
François Grolleau
Postdoctoral Scholar, Biomedical Informatics
BioFrançois Grolleau MD, MPH, PhD is a Postdoctoral Scholar at the Stanford Center for Biomedical Informatics Research. His research work centers on developing and evaluating computational systems that use large language models and other advanced methods from statistics and machine learning to assist medical decision-making.
François is a certified Anesthesiologist and Critical Care Medicine specialist from France. He holds an MPH degree and a PhD in Biostatistics from Paris Cité University. In 2016/2017, he worked as a research fellow in the Department of Health Research Methods, Evidence, and Impact at McMaster University, Canada (Profs Yannick Le Manach and Gordon Guyatt). During his doctorate with Prof. Raphaël Porcher, he utilized causal inference, personalized medicine methods, and statistical reinforcement learning for medical applications in the ICU. -
Cassandra Gross
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Cassandra Gross is a physician specializing in internal medicine and geriatric medicine, with a clinical focus on post-acute and long-term care. Dr. Gross is passionate about empowering older adults to make healthcare decisions that reflect what matters most to the individual and collaborating with interdisciplinary teams to deliver high quality care. Her academic interests include medical education in the skilled nursing facility setting, improving LGBT+ care across the continuum of care, and optimizing nutrition in older adults. She leads a Sustainable Practices Curriculum for geriatrics fellows to help foster self- reflection and career resilience.
-
Eric R. Gross
Associate Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsA part of the laboratory studies organ injury and how common genetic variants may affect the response to injury caused by surgery; particularly aldehydes. Aldehyde accumulation can cause many post-operative complications that people experience during surgery- whether it be reperfusion injury, post-operative pain, cognitive dysfunction, or nausea. The other part of the lab studies the impact of e-cigarettes and alcohol, when coupled with genetics, on the cardiopulmonary system.
-
James Gross
Ernest R. Hilgard Professor, Professor of Psychology and, by courtesy, of Philosophy
Current Research and Scholarly InterestsI am interested in emotion and emotion regulation. My research employs behavioral, physiological, and brain measures to examine emotion-related personality processes and individual differences. My current interests include emotion coherence, specific emotion regulation strategies (reappraisal, suppression), automatic emotion regulation, and social anxiety.
-
Elisabeth Grosvenor
Life Science Research Professional 1, Pediatric Anesthesiology
BioElisabeth Grosvenor is a research assistant with a background in social and environmental science research. She supports the HEAL-AI's interdisciplinary team, with a focus on streamlining processes and translating the team's novel work into accessible materials. She plans to continue leveraging qualitative and quantitative methodologies to better understand and improve scientific research.
-
Monica Grover
Clinical Associate Professor, Pediatrics - Endocrinology
BioCLINICAL FOCUS:
- Pediatric Endocrinology
- Pediatric Diabetes
- Pediatric Bone Health
